Company: STAA
Filing Date: 2025-09-24
Form Type: DEFC14A
Source: 0001213900-25-090869
Chunk: 11

Company: STAAR SURGICAL CO
Filing Date: 2025-09-24
Form: DEFC14A
Chunk 11
---
/Files/S/staar-surgical/investors/quarter-report/staar-surgical- 
 costaa-us-q1-2025-earnings-call-07052025.pdf (May 7, 2025).                                                                                               |

| 21 | Id. |

| 23 | Id. |

| 25 | Id. |

| 28 | Id. |

| 29 | See id. at 40. |

<div align='center'>6</div>

On
the Company’s earnings call in May 2025, the Company’s CEO proclaimed that “better days are ahead”30
for the Company. We agree.

Over
the last few months, the Company has taken actions to meaningfully reduce expenses and has been working with its distributors to manage
inventory levels and mitigate the impact of tariffs.31 With ICL demand in China “getting
stronger,”32we believe the Company will quickly return to revenue growth and accelerated
profitability which, in turn, we expect to drive greater value for stockholders.

As STAAR’s
largest stockholder, if the Proposed Merger is defeated—as we believe it should be—we are prepared to support the Company
with the recruiting and nomination of new directors and executives, if necessary, to ensure that the Company fulfills its promise to patients,
employees, business partners and stockholders.

The uncompelling
Merger Agreement Proposal before stockholders today appears to us to be the result of suboptimal timing and a flawed process, and the
price appears to reflect near-term pessimism and market dynamics rather than the Company’s intrinsic value. We are confident that
STAAR can deliver near- term value to stockholders far in excess of the $28 per share that Alcon is offering and that, in the long term,
the Company can build upon that value as it delivers on the promise of its unique technology and assets.

We
oppose the Proposed Merger on that basis and urge other stockholders to join us in doing so by voting “AGAINST” the
Merger Agreement Proposal on the GREEN Proxy Card.

Vote Required

According
to the Company’s proxy statement, the approval of the Merger Agreement Proposal requires the affirmative vote of the holders of
a majority of the outstanding shares of Common Stock entitled to vote thereon. If a quorum is present, abstentions and “broker non-votes”
will have the same effect as a vote “AGAINST” the Merger Agreement Proposal. Nevertheless, we urge stockholders to vote “